Skip to main content
. 2021 Jun 6;6(5):100736. doi: 10.1016/j.adro.2021.100736

Table 2.

Treatment characteristics for individual target lesions

Characteristic median (range) All targets (n = 374) Framed cases (n = 220) Frameless cases (n = 154)
Prescription dose 20 Gy (11.5-24) 23 Gy (11.5-24) 20 Gy (15-24)
Isodose line 57% (48-86) 50% (48-86) 50% (50-80)
Target volume 0.055 mL (0.002-8.61) 0.057 mL (0.002-8.61) 0.049 mL (0.003-6.65)
Treatment Time 39 mins (5-240) 69 mins (10-240) 31.5 mins (5-119)
Target coverage 100% (99-100) 100% (99-100) 100% (99-100)
Interruptions 0 (0-4) 0 (0-3) 0 (0-4)